FDA Clearance Tracker · K232464
VereSee Optical Veres Needle System
Last checked: Nov 20, 2026Latest source record: May 2, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 2, 2024
Substantially Equivalent
Time to decision
261 days
Received Aug 15, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K232464
- Device name
- VereSee Optical Veres Needle System
- Applicant
- Freyja Healthcare, LLC
- Applicant location
- North Andover, MA
- Received
- Aug 15, 2023
- Decided
- May 2, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Insufflator, Laparoscopic (HIF)
- Device class
- Class II
- Regulation
- 21 CFR 884.1730
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code HIF. The earliest in FDA's data is K772297, decided Jan 5, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232464
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Freyja Healthcare, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261139 · Decided Aug 13, 2026 · 128 days after receipt
Device type: Laparoscope, General & Plastic Surgery (GCJ) · GI, Urology & Nephrology
K252640 · Decided Oct 20, 2025 · 60 days after receipt
Device type: Laparoscope, General & Plastic Surgery (GCJ) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.